Stopping Weight Loss Injections: What You Should Know First

The myth that stopping is straightforward, and why it matters

A lot of people assume that once they have lost the weight, they can simply finish their last pen and that will be that. It is an understandable assumption; it is also where most difficulties begin.

GLP-1 and dual GIP/GLP-1 medicines like semaglutide (Wegovy) and tirzepatide (Mounjaro) reduce appetite and slow gastric emptying while they are in your system. Once the medicine clears (which takes a few weeks) those effects go with it. Your body's hunger signalling, which was always the thing being managed rather than cured, tends to reassert itself. The NHS patient information for tirzepatide is clear that this is a weight-management treatment, not a permanent fix applied in a course.

This is not a reason to stay on treatment indefinitely; it is a reason to think about stopping as a clinical decision rather than a logistical one. Questions worth raising with your prescriber: how much weight have you lost, how stable is that loss, what lifestyle changes are well established, and what does the next phase of your care look like? Those answers shape everything else. You can read more about what happens when you stop weight loss injections in detail if you want the physiology unpacked further.

The myth that stopping is easy is worth correcting early, because it changes how people plan.

What the trial data shows about weight after stopping

The strongest evidence comes from extension data on semaglutide and, more recently, tirzepatide. In the STEP 1 extension study, participants who stopped semaglutide 2.4mg regained on average about two-thirds of the weight they had lost within a year of stopping, appetite and body weight largely returned toward baseline. Tirzepatide data follows a similar pattern. NICE's appraisal of semaglutide (TA875) specifically sets a maximum recommended treatment duration of two years and ties the medicine to ongoing specialist support, partly in recognition that long-term outcomes depend on what happens around the medicine, not just the medicine itself.

That does not mean stopping is always the wrong choice. Some people reach a weight that substantially reduces their health risks, build strong dietary and activity habits alongside treatment, and find stopping manageable. Others find the return of appetite more significant than expected. Both outcomes are real. Whether weight comes back, and how much, is genuinely individual, there is no single number that fits everyone.

One practical note: if you are considering stopping because of side effects rather than because treatment has run its course, that is a different conversation. Side effects often ease after the first few weeks or after a dose adjustment; your prescriber can review whether stopping is the right answer or whether there are other options.

How stopping actually works in practice

For most people, stopping tirzepatide or Wegovy does not require a gradual taper the way some other medicines do. You do not take smaller and smaller doses over several weeks in the way you might with a corticosteroid, for example. The medicine simply is not taken at the next scheduled injection. That said, your prescriber may recommend a different approach depending on your dose and your circumstances, so this is always worth confirming before you stop.

If you have been on a higher maintenance dose (10mg or 15mg tirzepatide, or 2.4mg semaglutide) appetite may return more noticeably than it would for someone who has been on a lower dose for a shorter time. Being prepared for that, and having a clear plan around food and activity, makes a real difference. Our clinical team at nume (sorry, at nume) reviews this kind of question regularly as part of ongoing care. If you want a broader view of whether stopping is the right move, that page covers the clinical decision points in more detail.

On the practical side: any used pens should be disposed of safely. A sharps container keeps that straightforward and is a legal requirement for pen disposal at home.

One thing worth keeping in mind when you are thinking about costs and duration: the conversation about what treatment looks like and what it includes is worth having with a prescriber before you start, not only when you are ready to stop. Knowing the likely arc of treatment from the beginning tends to lead to better decisions at both ends.

Timing and what to do next

There is no universally 'right' moment to stop. UK guidance does not name a target weight or a specific number of months after which you must come off these medicines. NICE's recommendation for semaglutide sets a two-year ceiling for NHS use in specialist services; private prescribing has more flexibility, and clinical suitability is assessed individually at every review. NHS England's guidance on weight management injections emphasises that treatment decisions should sit within an overall care plan, not be made in isolation.

If you are currently on treatment and wondering whether now is the right point to stop, the most useful first step is a conversation with your prescriber, and our page on whether you can stop weight loss injections at any time covers the clinical considerations worth thinking through beforehand. If you are thinking about starting and want to understand the full picture, including what stopping looks like, our guide to how to get weight loss injections through a clinically supervised route explains the process, while our weight loss injections page gives a broader overview of the treatments available.

At nume, every repeat order is reviewed by a real prescriber before it is approved. That same clinical relationship is there when you are considering stopping. Speak to our prescribers if you have questions about where you are in treatment and what your next step should look like.